Senseonics to Participate in the Jefferies Healthcare Conference
26 Mai 2022 - 10:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to participate in
the upcoming Jefferies Healthcare Conference in New York, NY.
Management is scheduled to present on Thursday, June 9, 2022 at
1:30pm ET. Interested parties may access a live and recorded
webcast of the presentation on the “Investor Relations” section of
the company’s website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics' CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220526005699/en/
Senseonics Investor Relations Contact: Philip Taylor
Investor Relations 415-937-5406 Investors@senseonics.com
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Fév 2023 à Mar 2023
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Mar 2022 à Mar 2023
